These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 33274236)

  • 1. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of
    Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
    Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring the Pharmacological Mechanisms of
    Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
    Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Based on Network Pharmacology Tools to Investigate the Mechanism of
    Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
    Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring the pharmacological mechanisms of
    Lu M; Ou J; Deng X; Chen Y; Gao Q
    Heliyon; 2023 Jun; 9(6):e17550. PubMed ID: 37416640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis.
    Chen Y; Liu Z; Yu Q; Qu X; Liu H
    Medicine (Baltimore); 2023 Dec; 102(50):e36580. PubMed ID: 38115356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of
    Shi H; Hou Y; Su X; Qiao J; Wang Q; Guo X; Gao Z; Wang L
    Ren Fail; 2022 Dec; 44(1):116-125. PubMed ID: 35172688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of
    Mao N; Xie X
    Open Med (Wars); 2024; 19(1):20240967. PubMed ID: 38841174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripterygium wilfordii Hook.f induced kidney injury through mediating inflammation via PI3K-Akt/HIF-1/TNF signaling pathway: A study of network toxicology and molecular docking.
    Yang S; Wang M; Li Z; Luan X; Yu Y; Jiang J; Li Y; Xie Y; Wang L
    Medicine (Baltimore); 2024 Feb; 103(6):e36968. PubMed ID: 38335377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
    Gao LD; Liu J; Huang YH; Wang BH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
    Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
    Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.
    Zhao X; Liu Z; Ren Z; Wang H; Wang Z; Zhai J; Cao D; Lyu S; Li L; Lang R; He Q
    Eur J Pharmacol; 2020 Aug; 880():173225. PubMed ID: 32464191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the bioactive ingredients and mechanism of Huangqi against diabetic retinopathy based on network pharmacology and experimental verification.
    Lin X; Bao M; Zhang X; Qirula S; Jiao C; Zhang D; Han J
    J Chin Med Assoc; 2024 Aug; 87(8):789-798. PubMed ID: 38780966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
    Jin D; Yu M; Li X; Wang X
    J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease.
    Zhang J; Huang Q; Zhao R; Ma Z
    BMC Complement Med Ther; 2020 Mar; 20(1):95. PubMed ID: 32293395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of ovarian toxicity of Hook.F. a study based on network pharmacology and molecular docking.
    Wang Z; Gong C; Li Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):62-72. PubMed ID: 35576115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
    He D; Li Q; Du G; Sun J; Meng G; Chen S
    Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology analysis and molecular docking using the Chinese herbal agent WYHX formula (according to Yan Dexin): Management of coronary artery disease.
    Wang ZY; Zhou M; Sun YN; Hu XZ
    Int J Clin Pharmacol Ther; 2024 Aug; 62(8):363-376. PubMed ID: 38916485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.